Advertising

The Seattle Times Company

NWjobs | NWautos | NWhomes | NWsource | Free Classifieds | seattletimes.com

Health


Our network sites seattletimes.com | Advanced

Originally published Sunday, January 20, 2008 at 12:00 AM

Print

Drug used to treat HIV gets approval from FDA

Tablets of the drug etravirine were approved Friday by the Food and Drug Administration for the treatment of HIV infection in adults who...

WASHINGTON — Tablets of the drug etravirine were approved Friday by the Food and Drug Administration for the treatment of HIV infection in adults who have failed treatment with other antiretrovirals.

Sold under the trade name Intelence, etravirine is a non-nucleoside reverse transcriptase inhibitor, or NNRTI, that helps to block an enzyme that the human immunodeficiency virus needs to multiply, the FDA said. It was approved for use in combination with other anti-HIV medications.

Etravirine can reduce the amount of HIV in blood and increase white blood cells that help fight off other infections, the FDA said. It also may reduce the risk of death or infections that can occur with a weakened immune system.

The government gave etravirine a priority review, a status granted to medications aimed at treating serious or life-threatening conditions. Tibotec Pharmaceuticals, a unit of Johnson & Johnson, said last July that it had requested etravirine be placed on a fast track for review.

"This is another significant new product for many HIV-infected patients who are NNRTI-resistant and whose infections are not responding to currently available medications," said Dr. Debra B. Birnkrant, director of the FDA's Division of Antiviral Products.

About 10 percent of new HIV patients are infected with a virus that doesn't respond to therapy with at least one AIDS drug, according to the U.S. Centers for Disease Control.

The drug is distributed by Tibotec Therapeutics, a division of Ortho Biotech Products of Bridgewater, N.J.

Copyright © 2008 The Seattle Times Company

More Health headlines...

Print      Share:    Digg     Newsvine

advertising

On the left hand, answers aren't easy

Getting active outside can bring sunshine to your winter

How to encourage healthy computing

Obese people asked to eat fast food for health study

Charlie Sheen claims AA has a 5 percent success rate — is he right?

Advertising

Video

Marketplace

 
Most read
Most commented
Most e-mailed
 
 

Most viewed imagesMore

Advertising